Latest filing published 02 Sept 2025 for Novonesis (Novozymes A/S), €1.9M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Tina Sejersgård Fanø: trading record in brief
Tina Sejersgård Fanø is a declared insider of Novonesis (Novozymes A/S), with filings sourced from Finanstilsynet DK. Over a trading history stretching from 26 April 2016 to 2 September 2025, the count stands at 5 filings.
The open-market record is one-sided, with 3 purchases worth €5.1M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €1.9M. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 2 September 2025: an open-market purchase of €1.9M, in Novonesis (Novozymes A/S). Most trades are made public on the day they happen. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.
Companies and markets linked to Tina Sejersgård Fanø
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 48,610 shares@ DKK 286.09060.1% of flowShareOutside a trading venueISIN DK0060336014DK:1386700Canonical exit: 1 Dec 2025 (T+90)
- 82,107 shares@ DKK 262.03160.2% of flowShareISIN DK0060336014DK:919174Canonical exit: 27 Apr 2020 (T+90)
- 11,459 shares@ DKK 349.71680.0021% mcap0.0% of flowShareISIN DK0060336014DK:919041
- 15,609 shares@ DKK 172.60216.4% of flowShareNovozymes’ custody account Time Number of share Average purchase price Transaction value DKKISIN DK0060336014DK:771917Canonical exit: 26 Jul 2017 (T+90)
- ShareISIN DK0060336014DK:708393
5 of 5 declarations